Munafa Stock Market Course + Intraday & FNO calls 
Crispr Therapeutics (CRSP) Technical (Analysis) Reports Crispr Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Crispr Therapeutics (CRSP)
Technical Analysis Report for USA stock CRSP Crispr Therapeutics. Dated: 18 Sep 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock CRSP Crispr Therapeutics then click here. or read Experts views on Crispr Therapeutics or Forecast & share price targets of Crispr Therapeutics
Crispr Therapeutics Opened at 58.00 and Closed at: 56.56, which is -1.36% of previous session's close. It moved within a range of 55.63 and 59.34
The session was a Bearish session with an average volume of 3382800, which is 11.39% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
A Dead cross was found 7 days back on short term averages
Support for tomorrow is 54.24 and resistance for tomorrow is 57.95
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 55.01, 53.47 resistance for tomorrow's hourly charts is 58.72, 60.89
10 Day SMA for Crispr Therapeutics (CRSP) is 53.89 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Crispr Therapeutics (CRSP) is 55.99 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Crispr Therapeutics (CRSP) is 52.89 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 53.14 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Crispr Therapeutics is 53.33 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Crispr Therapeutics is at 55.99 and 200 DMA is at 53.33, while 50 DMA and 100 DMA are at 52.89 and 53.14 respectively
Crispr Therapeutics (CRSP) moving average of 20 SMA is at 55.99 and 20 EMA is at 54.82
| Date | Closing Price | 20 SMA | 20 EMA |
| 18 Fri Sep | 56.56 | 55.99 | 54.82 |
| 17 Thu Sep | 57.33 | 56.07 | 54.64 |
| 16 Wed Sep | 52.21 | 56.2 | 54.36 |
| 15 Tue Sep | 51.83 | 56.24 | 54.59 |
| 14 Mon Sep | 52.95 | 56.36 | 54.88 |
| 11 Fri Sep | 51.72 | 56.39 | 55.08 |
Crispr Therapeutics (CRSP) moving average of 50 SMA is at 52.89 and 50 EMA is at 54.17
| Date | Closing Price | 50 SMA | 50 EMA |
| 18 Fri Sep | 56.56 | 52.89 | 54.17 |
| 17 Thu Sep | 57.33 | 52.83 | 54.07 |
| 16 Wed Sep | 52.21 | 52.81 | 53.94 |
| 15 Tue Sep | 51.83 | 52.95 | 54.01 |
| 14 Mon Sep | 52.95 | 53.13 | 54.1 |
| 11 Fri Sep | 51.72 | 53.31 | 54.15 |
Crispr Therapeutics (CRSP) moving average of 100 SMA is at 53.14 and 100 EMA is at 53.64
| Date | Closing Price | 100 SMA | 100 EMA |
| 18 Fri Sep | 56.56 | 53.14 | 53.64 |
| 17 Thu Sep | 57.33 | 53.08 | 53.58 |
| 16 Wed Sep | 52.21 | 53.02 | 53.5 |
| 15 Tue Sep | 51.83 | 53.01 | 53.53 |
| 14 Mon Sep | 52.95 | 52.98 | 53.56 |
| 11 Fri Sep | 51.72 | 53 | 53.57 |
Crispr Therapeutics (CRSP) moving average of 200 SMA is at 53.33 and 200 EMA is at 52.94
| Date | Closing Price | 200 SMA | 200 EMA |
| 18 Fri Sep | 56.56 | 53.33 | 52.94 |
| 17 Thu Sep | 57.33 | 53.3 | 52.9 |
| 16 Wed Sep | 52.21 | 53.28 | 52.86 |
| 15 Tue Sep | 51.83 | 53.29 | 52.87 |
| 14 Mon Sep | 52.95 | 53.29 | 52.88 |
| 11 Fri Sep | 51.72 | 53.3 | 52.88 |
Takeda Pharmaceutical has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Takeda Pharmaceutical, about 8.96% more returns!
Qiagen N has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Qiagen N, about 3.26% more returns!
Encompass Health has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Encompass Health, about 6.14% more returns!
Biohaven Pharmaceutical has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Biohaven Pharmaceutical, about 3.28% more returns!
Astrazeneca Plc has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Astrazeneca Plc, about 5% more returns!
Crispr Therapeutics has performed better than Urogen Pharma in short term. Holding Crispr Therapeutics could be a better choice for now!
Therapeuticsmd Inc has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Therapeuticsmd Inc, about 11.25% more returns!
Crispr Therapeutics has performed better than Sutro Biopharma in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Regenxbio Inc in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Ultragenyx Pharmaceutical in short term. Holding Crispr Therapeutics could be a better choice for now!
Pro Dex has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Pro Dex, about 15.42% more returns!
Crispr Therapeutics has performed better than Lexicon Pharmaceuticals in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Kala Pharmaceuticals in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Immutep in short term. Holding Crispr Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Healthcare Services in short term. Holding Crispr Therapeutics could be a better choice for now!
Champions Oncology has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Champions Oncology, about 11.79% more returns!
Catalyst Biosciences has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Catalyst Biosciences, about 3.42% more returns!
Crispr Therapeutics has performed better than Aytu Bioscience in short term. Holding Crispr Therapeutics could be a better choice for now!
Aquestive Therapeutics has performed better than Crispr Therapeutics in short term. You could have earned much better returns by investing in Aquestive Therapeutics, about 3.87% more returns!
Crispr Therapeutics Technical analysis of indicators
Price action analysis of Crispr Therapeutics (CRSP) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Crispr Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Crispr Therapeutics in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Crispr Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a buy signal for Crispr Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Crispr Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 54.47 and Crispr Therapeutics CRSP stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Crispr Therapeutics CRSP stock. Volume based technical analysis of Crispr Therapeutics CRSP stock is negative.
Crispr Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock CRSP Crispr Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And CRSP Experts View which covers a lot of information including buying and selling signals
CRSP future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Crispr Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Crispr Therapeutics (CRSP) Technical (Analysis) Reports Crispr Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
